Anthem Biosciences Ltd.
Fundamentals
- Market cap
- ₹42,899 cr
- P/E
- 72.49×
- ROE
- 18.73%
- Debt / equity
- 0.05
- Div yield
- 0.26%
- 52-week range
- 579.15 — 873.50
Company snapshot
Anthem Biosciences Ltd.
CDMO
₹44,516 cr
P/E 77.29×
Latest quarter · Jun 2026
Sales₹418 cr
Net profit₹120 cr
Op. margin+36.0%
EPS₹2.13
Strength & growth
Debt / equity0.02×
Current ratio3.79×
The timeline — 4 notes on Anthem Biosciences Ltd.
July 2026
- 27 Jul 26 · 10:54 AM IST Brief Brief · Earnings · Large cap
Anthem Q1 transcript adds nothing new to already-known results
The post-earnings call transcript confirms a 22.6% revenue drop and ₹120 cr profit, but offers no fresh data or guidance shift beyond the July 22 call.
- 21 Jul 26 · 4:40 PM IST Brief Brief · Earnings · Large cap
Anthem Biosciences Q1 revenue falls 23% as growth streak stalls
Revenue of **₹418 crore** down from **₹540 crore** a year earlier; net profit slips **12%** to **₹120 crore**. CRDMO segment contributes **₹341 crore**, specialty ingredients **₹77 crore**.